Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Stable pharmaceutical composition containing ethinylestradiol and norethindrone acetate

A technology of norethindrone acetate and composition, which is applied in the field of pharmaceutical preparations, can solve problems such as oxidative degradation and drug effect decline, and achieve the effects of improving stability, ensuring stability, and improving overall stability

Active Publication Date: 2022-03-04
北京联嘉医药科技开发有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Ethinyl estradiol is an orally bioavailable estrogen, which is used in almost all modern combined oral contraceptive formulations. The content in a single dose product is usually less than 100µg, and it is prone to oxidative degradation after exposure to air. decrease the effectiveness of the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stable pharmaceutical composition containing ethinylestradiol and norethindrone acetate
  • Stable pharmaceutical composition containing ethinylestradiol and norethindrone acetate
  • Stable pharmaceutical composition containing ethinylestradiol and norethindrone acetate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-5

[0051] The compound tablet of ethinyl estradiol and norethindrone acetate is prepared by fluidized bed wet granulation tablet technology, and the processing steps are as follows:

[0052] Weighing: Weigh each component according to the prescription in Table 1.

[0053] Main drug solution preparation: dissolve ethinyl estradiol, norethindrone acetate, and vitamin E in a mixed solvent of ethanol and chloroform 1:1 (v / v);

[0054] Screening: pass lactose and starch through a sieve with a pore size of 20 mesh;

[0055] Granulation and drying: Put the sieved material into a fluidized bed granulation pot, spray the main drug solution in a fluidized state, and then fluidize and dry at 40°C;

[0056] Screening: pass the dried material through a sieve with an aperture of 20 mesh;

[0057] Blending and tableting: add the prescribed amount of magnesium stearate to the sieved granules, mix evenly, and then press into 5mm round tablets.

[0058] Table 1 Example 1-5 Tablet Prescription ...

Embodiment 6

[0060] Embodiment 6 Determination of related substances

[0061] The tablet prepared by Example 1-5 was preserved for 3 months under 40°C / 75%RH condition, and the packaging condition was a heat-sealed high-density polyethylene bottle, and the high-performance liquid chromatography was used to measure 0 days and 3 tablets respectively. The amount of related substances in the monthly samples, the determination results are shown in Table 3.

[0062] The HPLC chromatographic conditions are: use octyl bonded silica gel as filler; use acetonitrile containing 0.5% phosphoric acid as mobile phase A, acetonitrile containing 0.5% phosphoric acid: water = 1:3 as mobile phase B, perform linearity according to Table 2 Gradient elution; flow rate is 1.6ml per minute; FLDex285nm, em350nm (6α-hydroxyethinylestradiol, 6β-hydroxyethinylestradiol and Δ9,11-ethinylestradiol), UV 210nm (other impurities); column temperature: 40ºC; Sample volume: 30µl.

[0063] Table 2 Gradient elution parameter ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a stable pharmaceutical composition containing ethinylestradiol and norethindrone acetate. Vitamin E is added, so that the stability of ethinylestradiol is improved; and by using a specific amount of vitamin E, the production of related substances of ethinylestradiol and norethindrone acetate is controlled at the same time, and the overall stability of the compound preparation is improved.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations. The invention provides a pharmaceutical composition for female contraception or treatment and prevention of climacteric syndrome with good stability. Background technique [0002] Oral contraceptives usually contain a combination of synthetic progestin and estrogen. Both of these two hormone compounds can promote the maturation of female accessory sex organs and the emergence of secondary sexual characteristics, and maintain normal sexual desire and reproductive function. The compound preparation of estrogen ethinyl estradiol and progestin norethindrone acetate (optical rotation -32° to -38°) can be used for female contraception and treatment or prevention of menopausal syndrome. [0003] Ethinyl estradiol is an orally bioavailable estrogen, which is used in almost all modern combined oral contraceptive formulations. The content in a single dose product is usually less than 100µg, and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/567A61K9/32A61K9/48A61K47/22A61K47/26A61K47/36A61P15/12A61P15/18
CPCA61K9/284A61K9/2013A61K9/2018A61K9/2059A61K9/4866A61K9/4858A61K31/567A61K47/22A61P15/12A61P15/18A61K2300/00
Inventor 陈艳钱云刘见见
Owner 北京联嘉医药科技开发有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com